Elucidating the molecular mechanisms underlying the therapeutic effects of 6-shogaol on Parkinson's disease.
AI interpretation is pending for this paper.
What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Ginger has beneficial effects on brain health and neurodegenerative diseases, including Parkinson's disease (PD). Among its constituents, 6-shogaol has been identified as a major bioactive compound; however, the molecular mechanisms underlying its neuroprotective effects in PD remain unclear. This study aimed to explore the potential signaling mechanisms associated with the effects of 6-shogaol in PD. RNA sequencing was performed to identify transcriptional changes induced by 6-shogaol. Network pharmacology was used to predict shared targets between 6-shogaol and PD, and molecular docking was conducted to evaluate potential interactions with candidate targets. BV2 microglial cells and a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model were used for biological validation. RNA sequencing analysis revealed that 6-shogaol significantly modulates inflammatory transcriptional networks and is associated with suppression of the Jak/STAT signaling pathway. Network pharmacology identified 58 overlapping targets between 6-shogaol and PD, with STAT3 emerging as a central hub in the interaction network. Molecular docking suggested a potential interaction between 6-shogaol and STAT3. Experimental validation showed that 6-shogaol reduced STAT3 phosphorylation and decreased pro-inflammatory mediators in BV2 cells. In the MPTP-induced PD mouse model, 6-shogaol improved motor performance, protected dopaminergic neurons, reduced glial activation, and attenuated Jak2/STAT3 phosphorylation in the brain. Together, these findings suggest that the neuroprotective effects of 6-shogaol may be associated with modulation of STAT3-associated inflammatory signaling, supporting its potential therapeutic relevance in PD.